The future of brain circuit-targeted therapeutics

被引:20
|
作者
Siddiqi, Shan H. [1 ,2 ]
Khosravani, Sanaz [1 ,3 ]
Rolston, John D. [1 ,4 ]
Fox, Michael D. [1 ,3 ]
机构
[1] Brigham & Womens Hosp, Ctr Brain Circuit Therapeut, Boston, MA 02115 USA
[2] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA
[3] Harvard Med Sch, Dept Neurol, Boston, MA USA
[4] Harvard Med Sch, Dept Neurosurg, Boston, MA USA
关键词
TRANSCRANIAL MAGNETIC STIMULATION; POSTTRAUMATIC-STRESS-DISORDER; CORTICAL EXCITABILITY; THETA-BURST; FUNCTIONAL CONNECTIVITY; BRIEF EXPOSURE; DEPRESSION; NETWORKS; RTMS; TMS;
D O I
10.1038/s41386-023-01670-9
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The principle of targeting brain circuits has drawn increasing attention with the growth of brain stimulation treatments such as transcranial magnetic stimulation (TMS), deep brain stimulation (DBS), and focused ultrasound (FUS). Each of these techniques can effectively treat different neuropsychiatric disorders, but treating any given disorder depends on choosing the right treatment target. Here, we propose a three-phase framework for identifying and modulating these targets. There are multiple approaches to identifying a target, including correlative neuroimaging, retrospective optimization based on existing stimulation sites, and lesion localization. These techniques can then be optimized using personalized neuroimaging, physiological monitoring, and engagement of a specific brain state using pharmacological or psychological interventions. Finally, a specific stimulation modality or combination of modalities can be chosen after considering the advantages and tradeoffs of each. While there is preliminary literature to support different components of this framework, there are still many unanswered questions. This presents an opportunity for the future growth of research and clinical care in brain circuit therapeutics.
引用
收藏
页码:179 / 188
页数:10
相关论文
共 50 条
  • [41] THE FUTURE OF THERAPEUTICS
    不详
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1952, 67 (05) : 476 - 476
  • [42] Non-Invasive Delivery of Therapeutics into the Brain: The Potential of Aptamers for Targeted Delivery
    Bukari, Bakhtiar
    Samarasinghe, Rasika M.
    Noibanchong, Jinjutha
    Shigdar, Sarah L.
    BIOMEDICINES, 2020, 8 (05)
  • [43] Therapeutic Efficacy of Reward Circuit-Targeted Transcranial Magnetic Stimulation (TMS) on Suicidal Ideation in Depressed Patients: A Sham-Controlled Trial of Two TMS Protocols
    Huang, Xinyu
    Xi, Chunhua
    Fang, Ya
    Ye, Rong
    Wang, Xin
    Zhang, Shu
    Cui, Yuqiu
    Guo, Yang
    Zhang, Jingyi
    Ji, Gong-Jun
    Zhu, Chunyan
    Luo, Yuejia
    Chen, Xiaofen
    Wang, Kai
    Tian, Yanghua
    Yu, Fengqiong
    DEPRESSION AND ANXIETY, 2025, 2025 (01)
  • [44] The future of therapeutics
    Bodman, F
    BRITISH MEDICAL JOURNAL, 1932, 1932 (02): : 533 - 533
  • [45] Future prospects of nanoparticles on brain targeted drug delivery
    C. Chakraborty
    B. Sarkar
    C. H. Hsu
    Z. H. Wen
    C. S. Lin
    P. C. Shieh
    Journal of Neuro-Oncology, 2009, 93 : 285 - 286
  • [46] Future prospects of nanoparticles on brain targeted drug delivery
    Chakraborty, C.
    Sarkar, B.
    Hsu, C. H.
    Wen, Z. H.
    Lin, C. S.
    Shieh, P. C.
    JOURNAL OF NEURO-ONCOLOGY, 2009, 93 (02) : 285 - 286
  • [47] The emerging role of MMP14 in brain tumorigenesis and future therapeutics
    Ulasov, Ilya
    Yi, Ruiyang
    Guo, Donna
    Sarvaiya, Purvaba
    Cobbs, Charles
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2014, 1846 (01): : 113 - 120
  • [48] RNA-targeted therapeutics in cancer clinical trials: Current status and future directions
    Barata, Pedro
    Sood, Anil K.
    Hong, David S.
    CANCER TREATMENT REVIEWS, 2016, 50 : 35 - 47
  • [49] Blastic plasmacytoid dendritic cell neoplasm (BPDCN): A promising future in the era of targeted therapeutics
    Adimora, Ijele J.
    Wilson, Nathaniel R.
    Pemmaraju, Naveen
    CANCER, 2022, 128 (16) : 3019 - 3026
  • [50] Use of Targeted Therapeutics in Epithelial Ovarian Cancer: A Review of Current Literature and Future Directions
    Vetter, Monica Hagan
    Hays, John L.
    CLINICAL THERAPEUTICS, 2018, 40 (03) : 361 - 371